Impaired Endogen Fibrinolysis in Patients with Chronic Ischemic Heart Disease

Nurillaeva Nargiza Mukhtarkhanovna, Zokirova Muborakkhon Bobir qizi

dc.contributor.author	Nurillaeva Nargiza Mukhtarkhanovna, Zokirova Muborakkhon Bobir qizi
dc.date.accessioned	2024-01-16T04:16:45Z
dc.date.available	2024-01-16T04:16:45Z
dc.date.issued	2023
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/10252
dc.description.abstract	Cardiovascular disease is one of the main causes of mortality all of the world. Hypercoagulability is one of the pathogenetic mechanisms for the development of coronary heart disease. In our study, the main goal was to evaluate new markers of hypercoagulability and to establish the relationship between risk factors for coronary heart disease. Our results showed that The TAFI level in patients was authentically increased by 2.3 more time in patients compared to healthy individuals. At the same time, we found strong correlation between TAFI and the main risk factors of ischemic heart disease such as ADS, AH, obesity.	en_US
dc.language.iso	en	en_US
dc.publisher	Journal of Survey in Fisheries Sciences	en_US
dc.relation.ispartofseries	10(2S) 2329-2334;
dc.subject	Ischemic heart disease, hypercoagulation, Thrombin-activatable fibrinolysis inhibitor (TAFI), risk factors.	en_US
dc.title	Impaired Endogen Fibrinolysis in Patients with Chronic Ischemic Heart Disease	en_US
dc.type	Article	en_US